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37.4% of the women opting for prenatal testing, 30.3% (n = 
10) would terminate an affected pregnancy, 18.2% (n = 6) not 
and 51.5% (n = 17) could not decide (1 missing value).  Con-
clusion: A large majority of Turkish female immigrants would 
participate in preconception carrier screening for HbPs. 
 Copyright © 2010 S. Karger AG, Basel 
 Introduction 
 Hemoglobinopathies (HbPs) are diseases caused by 
some malfunction in the hemoglobin molecule and 
make up a common class of genetic recessive disorders, 
with about 4.5% of the world’s population carrying a
mutation for thalassemias or sickle cell disease  [1–3] . Pop-
ulations in Asia, Africa, the Middle East, Southern Eu-
rope, and the Caribbean have the highest prevalence
of HbPs or hemoglobin disorders. As a result of global 
population movements, however, hemoglobin disorders 
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 Abstract 
 Background: Preconception carrier screening for hemoglo-
binopathies (HbPs) is debated in the Netherlands.  Objec-
tives: Intentions to participate in preconception carrier 
screening for HbPs as well as informed reproductive options 
were assessed in 109 Turkish female immigrants.  Method: 
Participants completed a structured questionnaire.  Results: 
83.5% of 109 Turkish female immigrants intended to partici-
pate in preconception carrier screening. Intention to partici-
pate was related to the desire to reduce uncertainty about 
having offspring affected by HbPs, but not with socio-demo-
graphic variables, risk-estimation and worrying. If the tests 
concerning carrier status for HbPs were confirmative for 
both partners, 36.3% (n = 33) of the women with the inten-
tion of preconception carrier screening would refrain from 
getting children of their own, including 14.3% (n = 13) opting 
for adoption, 37.4% (n = 34) would decide to become preg-
nant and to opt for prenatal testing on HbPs. Finally, among 
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(thalasse mias and sickle cell disorders) are increasingly 
common in the formerly nonindigenous countries of 
Northern and Western Europe and in the indigenous 
countries of Southern Europe, which changing picture 
has consequences for needs of genetic services  [4] . The 
Netherlands is home to a large number of immigrants
(n  1 2,000,000); between 4% and 10% of them may be 
HbP carriers  [5] . In the Netherlands, about 40 to 60 chil-
dren are born each year with a severe form of hemoglo-
binopathy  [6] . Without preventive measures, such as pre-
conception and prenatal counseling and possibly the ter-
mination of pregnancy, in the next decade the incidence 
will rise to at least 1,000 severely affected patients  [7] . 
These patients only will be able to survive with intensive 
medical treatment and likely with a severely impaired 
quality of life. Additionally, unaware of their carrier sta-
tus, carrier couples are often totally unexpectedly con-
fronted with an affected child  [8] . On the one hand, 
Streetly  [8] , for example, emphasizes the need to provide 
good quality services for people affected by these condi-
tions, mentioning ‘genuine informed choice must enable 
parents to choose to continue with an affected pregnan-
cy in the knowledge that appropriate care is available’. 
On the other hand, Streetly argues that ‘the possibility of 
prenatal screening for HbPs would mean an end to sur-
prise diagnoses among infants presenting with severe 
overwhelming infections and splenic crises’  [8] . More-
over, prenatal testing enables an informed choice for oth-
er preventive measures.
 Additionally, it would seem important to offer the at-
risk population preconception carrier screening, so that 
couples can make informed reproductive decisions be-
fore pregnancy. The advantage of acquiring this informa-
tion before pregnancy is that there is less time constraint 
and a maximum of reproductive options (prenatal diag-
nosis followed or not followed by pregnancy termination, 
refraining from having (more) children, adoption, mak-
ing use of donor sperm/eggs, or preimplantation genetic 
diagnosis)  [9, 10] .
 In Mediterranean countries, the severity of the dis-
eases has led to successful prevention strategies, such as 
carrier screening for couples before marriage, which has 
resulted in considerable decline of the incidences of he-
moglobin disorders  [11–13] .
 Although prenatal testing is accepted in the Nether-
lands, preconception carrier screening is still debated. In 
most western industrialized countries, there has been an 
ongoing discussion about the ethical aspects of offering 
carrier screening for autosomal recessive genetic disor-
ders. Although the offer of screening, based on informed 
consent, might result in preventive management options, 
it might also increase anxiety in eligible couples. More-
over, the offer of screening might compromise the cou-
ple’s autonomy. Availability of screening may increase the 
social pressure to seriously consider and apply for screen-
ing. Positive outcomes could result in lowered self-es-
teem, stigmatization, discrimination and denial of health 
and life insurance, and employment opportunities  [9, 10, 
14, 15] .
 There is an additional argument for the danger of vic-
tim blaming in immigrant populations, because of the 
relationship between consanguineous marriages and risk 
of affected children  [16, 17] . Consanguineous marriage 
increases the chance that both members of a couple will 
carry any recessive variant that is being transmitted in 
their family and that this will manifest in the homozy-
gous state in their children  [18] . The risk of an autosomal 
recessive hereditary disorder increases by 2–3% in a rela-
tionship between cousins  [19] . However, in a population 
where 4–10% of the people are carriers of HbPs anyway, 
the additional risk of the consanguineous relationship is 
relatively lower. Additionally, several expert groups have 
emphasized the social importance of consanguineous 
marriages and have warned against the discouragement 
of consanguineous marriages on medical grounds  [18] . 
Interestingly, measures to prevent the birth of children 
affected by HbPs, such as premarital screening, preim-
plantation diagnosis and also termination of pregnancies 
in the first 100 days of gestation have been taken in many 
home countries of immigrants with the inclusion of Is-
lamic countries  [12, 18] . In contrast, however, few refer-
rals for genetic counseling for any hereditary or congeni-
tal disorder were observed in the Netherlands  [20] . The 
little use of genetic services by immigrants in the Neth-
erlands, compared to the native Dutch population, may 
be the result of misconceptions among health care profes-
sionals about the immigrants’ attitude and beliefs about 
genetics  [20–23] .
 In a Dutch empirical exploration among Turkish fe-
male immigrants (n = 82)  [21] , multivariate regression 
analyses showed that feelings of uncertainty, risk-estima-
tion and worrying about carrier status for an HbP were 
significant determinants of intentions to participate in 
preconception carrier screening for HbPs. Feelings of un-
certainty were included as determinants because in a 
study of Braithwaite et al.  [24] feelings of uncertainty 
emerged as a strong determinant of intention to partici-
pate in predictive genetic testing for hereditary cancer.
 In the current study we explored the intentions of 
Turkish female immigrants, living in the Netherlands, to 
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participate in preconception carrier screening for HbPs. 
Specifically, we aimed to answer the following research 
questions:
 (1a) What is the proportion of Turkish female immi-
grants planning to become pregnant who would intend 
to participate in preconception carrier screening for 
HbPs?
 (1b) If the result of the preconception carrier screening 
appeared to be unfavorable, what proportion of Turkish 
female immigrants would take the following additional 
measures to prevent offspring with HbPs: refrain from 
getting children of their own, including adoption of 1 or 
more children, prenatal testing and, in case of affected 
pregnancy, termination of pregnancy?
 (2) What is the role, if any, of socio-demographic char-
acteristics with regard to the intention to participate in 
preconception carrier screening for HbPs?
 (3) What is the role of psychological characteristics 
with regard to the intention to participate in preconcep-
tion carrier screening for HbPs?
 (4) What knowledge do Turkish female immigrants 
have about HbPs and their hereditary aspects?
 The study was approved by the Medical Ethical Re-
view Board of Erasmus University Medical Center, Rot-
terdam.
 Subjects and Methods 
 Participants and Procedure 
 Ten general practitioners (GPs) in Rotterdam (districts Delfs-
haven and Feyenoord) each consented to contact 20 Turkish fe-
male immigrants aged between 18 and 35 years who were plan-
ning to become pregnant. The GPs offered eligible women both 
oral and written information by a standard protocol. The infor-
mation concerned the objectives, design and conduct of the sci-
entific study and specifically dealt with the risks of having chil-
dren with HbPs and general aspects of heredity  [25, 26] . Leaflets 
were available in Dutch and in Turkish. The package also includ-
ed a prepaid reply letter and an informed consent form. The reply 
letter was to be returned if participants wished to receive a tele-
phone call from the female Turkish primary investigator (DM) to 
discuss the matter. A reminder was sent if neither the reply letter 
nor the informed consent letter was returned and, in almost all 
cases, followed by a telephone call from the Turkish researcher. As 
the initial strategy yielded an insufficient number of participants, 
the same GPs were asked to provide contact details of eligible 
Turkish female patients. These patients received the same written 
information together with information intended to clarify poten-
tial misconceptions and unrealistic expectations regarding the 
kind of commitment that the research would entail. After the tele-
phone call, all women but 1 consented to participate in the study. 
Next, the investigator arranged an interview at these women’s 
home addresses. The interviewer herself was a Turkish female im-
migrant, a master student in psychology with a good command 
of both Turkish and Dutch.
 Assessment 
 The informants were interviewed with the guidance of a struc-
tured questionnaire ‘Participation in carrier screening among 
migrants’ (The questionnaire is available at the address of the cor-
responding author). This structured questionnaire was based on 
previous focus group interviews and a pilot study  [21] . Interview-
ing took around 1 h 45 min. The questions concerned the follow-
ing issues:
 (1a) Intentions to participate in preconception carrier screen-
ing for HbPs. The preconception carrier screening was not actu-
ally offered. Instead, Turkish female immigrants were asked to 
imagine what decision they would make if the offer was made.
 (1b) Dependent upon the results of genetic screening for HbPs, 
intentions to take measures to avoid having offspring affected by 
HbPs (refraining from having offspring of their own including 
adoption, prenatal testing, termination of pregnancy in the case 
of finding their offspring were affected by HbPs).
 (2) Socio-demographic characteristics: age (divided at the me-
dian:  ! 25 or  6 25); country of birth (Turkey or the Netherlands); 
residency (living with or without partner; living with or without 
children); education (low i.e. elementary school or lower voca-
tional education versus medium i.e. secondary and medium vo-
cational education, and high i.e. higher secondary or vocational 
education; socio-economic status (SES) is represented as the high-
est educational level in the partnership (for single women their 
educational level represents their SES); marriage (consanguine-
ous or not); religion (active versus less active); pregnancy (yes or 
no), and carrier status of an HbP (yes or no) ( table 1 ).
 (3) Psychological characteristics: feelings of uncertainty  [24, 
27] (8 items adapted to preconception carrier screening for HbPs); 
risk-estimation of being a carrier of an HbP (1 item); worrying
(3 items). For a concise description of these items, see  table 2 .
 (4) Knowledge: previous knowledge about HbPs (1 item) and 
their hereditary aspects (1 item) ( table 1 ).
 Statistical Analyses 
 Beforehand, all variables were dichotomized, except educa-
tional level, SES and the intention to terminate an affected preg-
nancy. Counts and percentages were determined for all outcome 
and predictor variables. The potentialities of predictor variables 
were examined by the method of logistic regression analysis.
Adjusting for confounding was relevant in the relationships be-
tween intention to participate in preconception carrier testing 
and psychological characteristics. Candidate-confounding vari-
ables (age, partner, children, SES, pregnancy, consanguinity, be-
ing active in religion, and carrier status of an HbP) were entered 
simultaneously in the logistic regression analysis. To provide in-
sight into the impact of confounding variables in the relationships 
between intention to participate in preconception carrier testing 
and psychological characteristics, both adjusted and unadjusted 
results are presented in  table 2 . As a performance measure, the 
odds ratio (OR) is presented, including the 95% confidence inter-
val (95% CI). If the 95% CI did not include the value of odds ra-
tio = 1.00, then the determinant was considered to be significant 
at the 0.05 level (two-tailed). All statistical testing took place at a 
level of significance of 0.05 (two-tailed).
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 Results 
 Socio-Demographic Characteristics 
 In 2004 and 2005, 109 Turkish female immigrants in 
the Netherlands, aged between 18–36 years (x– = 25.61,
s = 5.37), patients of 10 GPs in Rotterdam and planning 
to become pregnant, consented to participate in the study. 
Eight pregnant female immigrants were included as well. 
All women’s parents and grandparents and their part-
ners’ parents and grandparents had been born in Turkey. 
Four females identified as carriers of an HbP were in-
cluded (1 female with sickle cell disease, 3 females with 
an unknown HbP); 2 of them with family members also 
identified as carriers of an HbP. In addition, 2 family 
members of females not identified as carriers were carri-
ers of an HbP. One person had a family member with an 
HbP and was included as well. Due to the very small 
numbers, these variables were not included in (analyses 
of)  table 1 .  Table 1 presents the socio-demographic data 
both in frequencies and percentages.
 Psychological Characteristics 
 Results concerning ‘Feelings of uncertainty’, ‘Risk-
estimation’ and ‘Worrying’ are presented in  table 2 .
Table 1.  Relationships between intention to participate in preconception carrier screening for HbPs and socio-demographic charac-
teristics (n = 109)
Intention to participate in preconception carrier screening Odds ratio 95% CI
n = 109, n ( %)a yes (n = 91), n (%)a no (n = 18), n (%)a
Ageb
≥25 50 (45.9) 42 (46.2) 8 (44.4) 1.07 0.39–2.96
<25 59 (54.1) 49 (53.8) 10 (55.6)
Country of birth
Turkey 63 (57.8) 53 (58.2) 10 (55.6) 0.90 0.32–2.48
The Netherlands 46 (42.2) 38 (41.8) 8 (44.4)
Residency
With partner 72 (66.1) 61 (67.0) 11 (61.1) 1.29 0.46–3.67
Without partner 37 (33.9) 30 (33.0) 7 (38.9)
With children 54 (49.5) 44 (48.4) 10 (55.6) 0.75 0.27–2.07
Without children 55 (50.5) 47 (51.6) 8 (44.4)
Education
Low 26 (24.3) 20 (22.5) 6 (33.3)
Middle 56 (52.3) 46 (51.7) 10 (55.6) 1.38 0.44–4.32
High 25 (23.4) 23 (25.8) 2 (11.1) 3.45 0.63–19.05
Socio-economic statusc
Low 17 (15.6) 12 (13.2) 5 (27.8)
Middle 58 (53.2) 49 (53.8) 9 (50.0) 2.27 0.64–8.01
High 34 (31.2) 30 (33.0) 4 (22.2) 3.13 0.72–13.67
Consanguinity
Yes 25 (22.9) 23 (25.3) 2 (11.1) 2.71 0.58–12.67
No 84 (77.1) 68 (74.7) 16 (88.9)
Religion
Active 62 (56.9) 49 (53.8) 13 (72.2) 0.45 0.15–1.36
Nonactive 47 (43.1) 42 (46.2) 5 (27.8)
Pregnancy
Yes 8 (7.3) 8 (8.8) 0 (0.0) 3.77 0.21–68.20
No    1 01 (92.7) 83 (91.2) 18 (100.0)
Knowledge of HbPs
Yes 14 (12.8) 12 (13.2) 2 (11.1) 1.22 0.25–5.96
No 5 (87.2) 79 (86.8) 16 (88.9)
a  Column percentages. b Age was divided into two categories at the median. c SES represents the highest education level in the part-
nership, for single women their educational level represents their SES.
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 Intentions to Participate in Preconception Carrier 
Screening and to Take Additional Preventive 
Measures in Case of Assumed Carrier Status for HbPs 
for Both Parents 
 Of the 109 women, 91 (83.5%) reported that they in-
tended to participate in preconception carrier screening, 
if it was offered.  Table 3 shows that, if the screening con-
firmed carrier status for HbPs for both partners, 36.3% 
(n = 33) of those 91 women would refrain from giving 
birth. Secondly, among these 33 females, 14.3% (n = 13) 
would opt for adoption. Thirdly, 37.4% (n = 34) of these 
91 females would try to become pregnant and then have 
prenatal testing, if offered. This means that 62.6% (n = 57) 
of these 91 women would have the intention to participate 
in preconception screening and not in antenatal testing. 
Finally, 30.3% (n = 10) of the 33 women who would have 
the intention to participate in prenatal testing would pre-
maturely terminate a pregnancy affected by severe forms 
of HbPs, while 18.2% of the 33 women (n = 6) would not 
prematurely terminate an affected pregnancy, and 51.5% 









95% CI Odds 
ratioc
95% CI
yes (n = 91), n (% )a no (n = 18), n (%)a
Uncertainty
I would rather be certain about being 
carrier or not than to live with uncertainty
89 (81.7) 78 (85.7) 11 (61.1) 3.82 1.25–11.64 4.93 1.37–17.73
I would like to know now if I’m a carrier so 
I can get used to the situation
75 (68.8) 69 (75.8) 6 (33.3) 6.27 2.11–18.68 6.28 1.94–20.36
If I didn’t have a genetic test I would always 
be wondering whether I was going to get 
children with an HbP
77 (70.6) 70 (76.9) 7 (38.9) 5.24 1.80–15.21 6.37 1.87–21.67
The relief I would get from a good result 
makes it worth the risk that the result is bad
94 (86.2) 83 (91.0) 11 (61.1) 6.60 2.00–21.78 6.53 1.61–26.42
I think it is tempting fate to ask questions 
about the future health of our children
64 (58.7) 55 (60.4) 9 (50.0) 1.53 0.55–4.22 1.22 0.40–3.66
I would rather live with uncertainty, than 
find out I could get children with an HbP
90 (82.6) 81 (89.0) 9 (50.0) 8.10 2.61–25.17 7.33 2.06–26.16
Knowing the result of a genetic test would 
mean I felt more in control
85 (78.0) 74 (81.3) 11 (61.1) 2.77 0.94–8.19 3.15 0.89–11.12
It is better to know that I can get children 
with an HbP, even if I can’t prevent it
90 (82.6) 80 (87.9) 10 (55.6) 5.82 1.89–17.89 5.95 1.50–23.60
Risk-estimation
What is the probability that you are carrier 
of an HbP? (high)
44 (40.4) 40 (44.0) 4 (22.2) 2.75 0.84–8.99 2.46 0.69–8.82
Worrying
Are you worrying right now about being 
carrier of an HbP? (yes)
27 (24.8) 25 (27.5) 2 (11.1) 3.03 0.65–14.14 3.63 0.71–18.70
Are you worrying right now about getting 
children with an HbP? (yes)
27 (24.8) 23 (25.3) 4 (22.2) 1.18 0.35–3.96 1.08 0.30–3.93
Are you worrying right now about 
undergoing a carrier test for an HbP? (yes)
19 (17.4) 16 (17.6) 3 (16.7) 1.07 0.28–4.12 1.10 0.26–4.60
a Column percentages. b Unadjusted odds ratio. c Odds ratio adjusted for age, partner, children, SES, pregnancy, consanguinity, being active in reli-
gion, and carrier status of an HbP.
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(n = 17) did not know what they would decide. The data 
for this item was missing for 1 of the 34 Turkish female 
immigrants.
 If both parents turned out to be a carrier, 29 of 91 fe-
males with the intention to participate in preconception 
carrier screening answered ‘no’ on all 4 preventive mea-
sures. The intention to take one or more preventive mea-
sures versus no preventive measure at all was neither sta-
tistically significant related to ‘having children or not’
(p = 0.60), nor to ‘being active in religion or not’ (p = 0.20).
 With respect to the intention to take specific preven-
tive measures in case of carriership in both spouses, no 
significant differences were found between Turkish fe-
male immigrants with and without the intention to par-
ticipate in preconception carrier screening. However, 
there was a marginal statistical significance (  2 = 2.87;
p  ! 0.07) for intention to participate in prenatal testing 
under these circumstances, with a larger proportion of 
women in the affirmative group with respect to precon-
ception carrier screening.
 Relationships between Intention to Participate
in Preconception Carrier Screening for HbPs and 
Socio-Demographic Characteristics 
 Logistic regression analyses revealed that none of the 
socio-demographic characteristics had a significant rela-
tionship with regard to intentions to participate in pre-
conception carrier screening for HbPs ( table 1 ).
 Relationships between the Intention to Participate 
in Preconception Carrier Screening for HbPs and 
Psychological Characteristics 
 Logistic regression analyses, both adjusted and un-
adjusted for confounding socio-demographic variables, 
suggested that all uncertainty items except 2 of them
(‘I think it is tempting fate to ask questions about the fu-
ture health of our children.’ and ‘Knowing the result of a 
genetic test would mean I felt more in control.’), proved 
to have statistically significant relationships with inten-
tion to participate in preconception carrier screening for 
HbPs. The wish to reduce uncertainty therefore went 
along with intention to participate in carrier screening. 
However, risk-estimation of being a carrier of an HbP and 
worrying about carrier status, having affected children 
and undergoing preconception carrier testing could not 
be considered of significant relevance to the intention to 
participate in preconception carrier screening.
 Knowledge about HbPs and Their Hereditary 
Characteristics 
 Seventy-seven women in our study (70.5%) had never 
heard about HbPs, 18 (16.5%) knew about HbPs but did 
not know they are hereditary and only 14 (13.0%) knew 
about HbPs as hereditary diseases. Knowledge about 
HbPs and their hereditary characteristics did not have a 
significant relationship with the intention to participate 
in preconception carrier screening for HbPs ( table 1 ).
 Discussion 
 The large majority of the Turkish women who partici-
pated in this study would have the intention to participate 
in preconception carrier screening, if it was offered to 
them. It would seem, therefore, that the policy of offering 
this possibility is highly acceptable among female Turk-
ish immigrants in the Netherlands. In agreement with 
these findings, many parents from immigrant popula-
tions in the UK were positive about preventive measures 
for HbPs. Interestingly, surveyed people even complained 
Table 3.  Intention to take additional preventive measures in case of confirmed carrier status for HbPs for both 
partners
% (n) 95% CI 
Decision to refrain from having own offspring (n = 91) 36.3 (33) 26.4–46.2
Adoption (n = 91): a subgroup of females belonging to the group of 
33 females refraining from having own offspring 14.3 (13) 7.1–21.5
Prenatal testing (n = 91) 37.4 (34) 27.5–47.3
Termination of affected pregnancy (n = 33, one missing value)
Yes 30.3 (10) 14.6–46.0
No 18.2 (6) 5.0–31.4
Don’t know 51.5 (17) 34.4–68.9
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that all kinds of measures would have a higher priority if 
HbPs were most prevalent in Caucasian populations  [22] . 
In Turkey, a large majority of a subset of the population 
(n = 179) was also willing to undergo genetic testing to 
determine cancer risk and to take preventive measures 
for themselves and their offspring  [28] . Despite this ac-
ceptability, however, there is a low uptake of genetic ser-
vices among immigrants in the Netherlands  [20] and oth-
er countries  [22] . The low uptake of genetic services for 
HbPs among immigrants has been attributed to a variety 
of factors. The most important of these are lack of knowl-
edge among general practitioners about these conditions 
and misconceptions about norms and values among im-
migrants  [22] . For example, health care providers as-
sumed that immigrants would refuse to terminate preg-
nancies and did not refer them. Hence, many parents 
were left with no choice. Ahmad and Atkin  [23] conclud-
ed that cultural myths could undermine accepted good 
medical practice.
 If the screening concerning carrier status for HbPs 
was confirmative for both parents, almost two-thirds of 
the informants concerned would still have their own off-
spring. A small minority would opt for adoption. One-
third of the informants would opt for prenatal testing of 
HbPs and one-third of the informants opting for prenatal 
testing would terminate a pregnancy affected by HbPs. 
From earlier research on an immigrant population of 
comparable age living in the Netherlands, it appeared 
that 68% of Hindustanis, 42% of Surinamese Afro-Amer-
icans and only 16% of Moroccans would decide to termi-
nate an affected pregnancy  [29] . The apparently limited 
wish for selective abortion expressed by Moroccans 
proved to be in contrast, however, with the high number 
of illegal abortions reported among married women in 
Morocco (39%)  [29] .
 It appears that the degree of acceptability of prenatal 
testing and termination of affected pregnancies among 
Turkish female immigrants in our study is relatively low. 
Data in our study, however, showed that the majority 
were hardly familiar with HbPs, let alone the clinical im-
plications of the diseases. Although the participants had 
been informed about HbPs shortly before the interview, 
they may not have had the opportunity to sufficiently as-
similate the knowledge and share it with other people of 
importance to them.
 Socio-demographic characteristics showed no signifi-
cant relationships with regard to intentions to participate 
in preconception carrier screening. Finding no difference 
between females with and without children regarding the 
intention to participate is in contrast to the study of Lake-
man et al.  [10] in which having children turned out to be 
a declining factor in carrier screening for cystic fibrosis 
(CF) and/or HbPs. Eight pregnant females were included 
as well: pregnant female immigrants were considered as 
capable as nonpregnant females to imagine what decision 
they would make when the offer was made. All pregnant 
females intended to participate in preconception carrier 
screening when the offer was made. Due to the small 
number of pregnant females, pregnancy was not found to 
have a statistically significant relationship with intention 
to participate ( table 1 ). Due to the very small number of 
female carriers (4), carrier status of an HbP was not in-
cluded in (analyses of)  table 1 .
 It seems that for most participants in the present study, 
the wish to reduce uncertainty induced the intention to 
participate in preconception carrier screening. In con-
trast, risk-estimation of being a carrier of an HbP and 
worrying about carrier status, having affected children 
and undergoing preconception carrier screening were not 
found to be relevant in this respect. More than half of the 
Turkish female immigrants thought it very unlikely or 
unlikely to be a carrier of an HbP. The vast majority did 
not report anxiety about carrier status, and a similar pro-
portion claimed not to worry about having children af-
fected by HbPs. Although our results, however, showed no 
significant relationship between intention to participate 
in preconception carrier screening and risk-estimation, 
51 out of 91 (56%) Turkish female immigrants who had the 
intention to participate in carrier screening estimated 
their risk of carrier status unlikely or very unlikely, while 
14 out of 18 (78%) females without intention to participate 
estimated this risk unlikely or very unlikely. In the same 
line of reasoning, the vast majority did neither report anx-
iety about carrier status, nor about having children af-
fected by HbPs. Again, although our results showed no 
significant relationship between the intention to partici-
pate in preconception carrier screening and worrying 
about carrier status, among females with the intention to 
participate in preconception carrier screening 27.5% were 
worrying about carrier status, while only 11.1% of females 
without intention to participate were worrying about car-
rier status. Research with a larger population of females 
might show that women, who perceive a high risk of car-
rier status and worry more about carrier status, are more 
willing to participate in preconception carrier screening.
 Additionally, we expect that with increased knowl-
edge about the clinical implications of HbPs this popula-
tion will have a more rational risk-estimation and will 
worry more about carrier status. As a consequence, more 
females might have the intention to participate in pre-
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conception carrier screening. More research with a larg-
er population is needed, however, on the relevance of
the interaction between risk-estimation, knowledge and 
worrying about the decision to participate in preconcep-
tion carrier screening.
 Strengths and Limitations of the Study 
 An advantage of this study was that a Turkish female 
immigrant interviewer from the same city of Rotterdam, 
with a good command of both Turkish and Dutch, in-
formed and interviewed the participants in our study. In 
addition, our study was preceded by focus group inter-
views and pilot-studies concerning knowledge of HbPs, 
attitudes and intentions for preconception carrier screen-
ing for HbPs and other genetic services  [20, 21] . Therefore, 
we knew that Turkish female immigrants were hardly fa-
miliar with HbPs and the clinical and hereditary implica-
tions. As a consequence, the Turkish female immigrants 
in our study were offered extensive information about 
these subjects shortly before they were asked to partici-
pate. A limitation of this study was that we could not ac-
tually offer preconception carrier screening. There could 
be a discrepancy between intentions and actual behavior, 
as explained in the Theory of Planned Behavior  [30] . A 
second limitation was that the number of females not in-
tending to participate in preconception carrier screening 
was too small to draw strong conclusions. Finally, the 
study was conducted in 1 city; we need to expand our 
study nationwide to increase the generalizability.
 Conclusions 
 The acceptability of preconception carrier screening 
among the studied population of Turkish female immi-
grants is high. However, it appears that the degree of ac-
ceptability of prenatal testing and termination of affect-
ed pregnancies among the studied Turkish females is 
relatively low. Taken into account that the participants in 
our study were hardly familiar with the hereditary and 
clinical implications of HbPs, more health education and 
genetic counseling about HbPs is needed to reach sound 
informed decision-making. The first steps towards bet-
ter education have already been made. For example, in 
2005 the National Genetic Information Centre (Stichting 
Er focentrum) in cooperation with the Municipal Mental 
Health Center of Amsterdam set up a series of health 
education meetings about hemoglobin disorders  [31] . 
Visitors could watch stage plays in several languages 
(Turkish, Moroccan, Papiamento, Sranan Tongo, Dutch 
and English) and attend panel discussions featuring ex-
perts on these disorders  [31] . Subsequently, in 2006, the 
National Genetic Information Centre in cooperation 
with the Erasmus Medical Center, Rotterdam developed 
‘Pregnancy and Risk’ (Zwangerwijzer), a self-report 
questionnaire aimed at providing information about 
pregnancy risks  [32] . Part of the questionnaire deals with 
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